Central America Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
September 17, 2014
73 Pages - SKU: BMI5329127
Countries covered: Central America

Central America Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Costa Rica and Panama will continue to outperform other Central American countries, namelyEl Salvador, Guatemala, Honduras, Nicaragua and Belize. The business-friendly environment, high percapitamedicine spending and strong consumer demand still present strong revenue-generatingopportunities for multimodal pharmaceutical companies.

Headline Expenditure Projections

Pharmaceuticals: USD3.5bn in 2013 to USD3.7bn in 2014; +4.1%. Our forecast has been revisedslightly down since Q314 due to less promising industry data.

Healthcare: USD16.0bn in 2013 to USD16.8bn in 2014; +4.8 %. Our forecast has been reviseddownwards since Q314 due to revised historical data.



More Prescription Drugs reports by Business Monitor International

Japan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Japan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Japanese pharmaceutical market continues to hold strong rewards for innovativepharmaceutical companies. This is driven by the ...
Tanzania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect the continuing depreciation of the Tanzanian shilling to make imports of rawmaterials increasingly expensive for ...
Romania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Romania Pharmaceuticals and Healthcare Report Q1 2015BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push theburden ...
Latvia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Latvia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Market growth forecasts are strong although the country will continue to present a modestopportunity to larger multinational ...
See all reports like this >>

More Central America Prescription Drugs reports

Antibiotics Market in Panama to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Panama. The study provides essential market ...
See all reports like this >>

More Central America reports

D&B Country Report: Guatemala by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
D&B Country Report: El Salvador by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!